Search Videos and More

Showing 97 - 103 of 103 results

Previous| 1... 7 | 8 | 9 |Next


National Cancer Institute Redesignation Video

National Cancer Institute Redesignation

The National Cancer Institute has renewed the Harold C. Simmons Comprehensive Cancer Center’s comprehensive designation, reaffirming its place among the country’s elite cancer institutes.
PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients News

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

UT Southwestern is leading research to find ways to extend the benefits of PARP-1 inhibitor maintenance medication to more patients with more forms of ovarian cancer.
Artificial Intelligence Algorithm Developed to Assess Metastatic Potential in Skin Cancers News

Artificial Intelligence Algorithm Developed to Assess Metastatic Potential in Skin Cancers

Using artificial intelligence (AI), researchers from UT Southwestern have developed a way to accurately predict which skin cancers are highly metastatic.
The Consequences of Understaging Gastric Cancer News

The Consequences of Understaging Gastric Cancer

Patients with nonspecific symptoms that overlap with the symptoms of gastric cancers should be evaluated at a center with extensive experience in treating these cancers.
CAR T-Cell Therapy Fights Cancer with a Live Weapon Video

CAR T-Cell Therapy Fights Cancer with a Live Weapon

By harnessing the full force of a patient's immune system, the targeted approach of CAR T-cell therapy makes it possible to mount a highly effective attack against certain cancers.
Behind The Scenes: A Day in the Life of an Emergency Medicine Resident Video

Behind The Scenes: A Day in the Life of an Emergency Medicine Resident

What's it like to be an emergency medicine resident? Edmond (Eddie) Irankunda, MD, is a third-year resident in the University of Cincinnati Emergency Medicine Program, the first in the country.
Novel Biomarker Might Lead to Personalized, Targeted Therapy News

Novel Biomarker Might Lead to Personalized, Targeted Therapy

ADP-ribosylation could help scientists predict PARP inhibitor sensitivity in ovarian and breast cancer patients.

Showing 97 - 103 of 103 results

Previous| 1... 7 | 8 | 9 |Next